|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.590 CNY | +1.77% |
|
+9.29% | -17.00% |
| 25/05 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 24/04 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 787.52Cr 116.02Cr 101.43Cr 93Cr 87Cr 164.79Cr 11TCr 167.29Cr 1.12TCr 435.01Cr 5.43TCr 435.5Cr 426.15Cr 19TCr | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.75TCr 258.54Cr 226.02Cr 207.71Cr 193.61Cr 367.22Cr 25TCr 372.79Cr 2.49TCr 969.38Cr 12TCr 970.46Cr 949.62Cr 42TCr | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.58% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | +1.77% | ||
| 1 week | +9.29% | ||
| Current month | +7.49% | ||
| 1 month | +3.61% | ||
| 3 months | -16.70% | ||
| 6 months | -17.74% | ||
| Current year | -17.00% |
| 1 week | 4.21 |  | 4.62 |
| 1 month | 4.11 | | 4.66 |
| Current year | 4.11 | | 6.07 |
| 1 year | 4.11 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Li Xin Wang
CHM | Chairman | 54 | 10/04/2023 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/25/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.77% | +9.29% | -28.84% | -18.04% | 116.02Cr | |
| +1.86% | +0.48% | +55.50% | +160.66% | 1,08200Cr | |
| +3.57% | +3.29% | +68.60% | +61.56% | 63TCr | |
| +3.99% | +3.05% | +37.93% | +89.70% | 46TCr | |
| -0.26% | +1.37% | +31.00% | +23.05% | 34TCr | |
| -0.56% | +0.96% | +39.86% | +36.12% | 30TCr | |
| -0.08% | +1.30% | +30.37% | +43.79% | 29TCr | |
| -1.54% | +2.81% | -27.56% | -40.35% | 22TCr | |
| +3.55% | +4.41% | +25.45% | +65.64% | 20TCr | |
| +4.21% | +2.65% | +17.47% | +69.95% | 16TCr | |
| Average | +1.65% | +4.42% | +24.98% | +49.21% | 36.94TCr | |
| Weighted average by Cap. | +1.87% | +5.43% | +41.73% | +81.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 986.96Cr 145.4Cr 127.11Cr 116.82Cr 108.89Cr 206.53Cr 14TCr 209.66Cr 1.4TCr 545.18Cr 6.81TCr 545.79Cr 534.07Cr 23TCr | 924.17Cr 136.15Cr 119.02Cr 109.38Cr 101.96Cr 193.39Cr 13TCr 196.32Cr 1.31TCr 510.49Cr 6.37TCr 511.06Cr 500.09Cr 22TCr |
| Net income | 13Cr 1.87Cr 1.64Cr 1.5Cr 1.4Cr 2.66Cr 178.14Cr 2.7Cr 18Cr 7.01Cr 88Cr 7.02Cr 6.87Cr 301.74Cr | 18Cr 2.7Cr 2.36Cr 2.17Cr 2.02Cr 3.83Cr 256.78Cr 3.89Cr 26Cr 10Cr 126.22Cr 10Cr 9.91Cr 434.95Cr |
| Net Debt | 978.97Cr 144.23Cr 126.08Cr 115.87Cr 108Cr 204.85Cr 14TCr 207.96Cr 1.39TCr 540.76Cr 6.75TCr 541.37Cr 529.74Cr 23TCr | 967.38Cr 142.52Cr 124.59Cr 114.5Cr 106.73Cr 202.43Cr 14TCr 205.5Cr 1.37TCr 534.36Cr 6.67TCr 534.96Cr 523.48Cr 23TCr |
Employees
9,972
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | CN¥4.590 | +1.77% | 2,04,42,246 |
| 02/26/02 | CN¥4.510 | +1.12% | 2,27,98,307 |
| 01/26/01 | CN¥4.460 | +4.45% | 2,47,61,326 |
| 30/26/30 | CN¥4.270 | -3.17% | 1,77,83,322 |
| 29/26/29 | CN¥4.410 | +5.00% | 2,60,84,326 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
